Dr. Valencia Humphrey holds a Bachelor of Science in Biology (Pre-Med) from Norfolk State University, Master of Science in Regulatory Affairs for Drugs, Biologics, and Medical Devices from Northeastern University, and a Doctor of Public Health (DrPH) degree from Capella University. Dr. Humphrey has also completed the Regulatory Affairs Training Program at Duke University School of Medicine to enhance her expertise in drug development and stay updated on the evolving FDA requirements for drug approval. As a scholar-practitioner, Dr. Humphrey’s doctoral manuscript centered on the utilization of Evidence-Based Practice, as an intervention to improve organizational strategies for enhancing racial and ethnic minority representation in lupus, both cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE), clinical trials, which is essential to ensure the safety and efficacy of investigational medicines in underrepresented populations.

As an Evidence-Based Practice facilitator-practitioner, Dr. Humphrey has honed her skills to assist clinicians and industry professionals in incorporating the best research evidence into clinical and industry practice, with the goal of enhancing population health. Dr. Humphrey is particularly interested in underserved populations and vulnerable groups, such as the elderly, pregnant women, and children. An avid breastfeeding advocate and breastfeeding counselor, Dr. Humphrey’s scholarly research has also delved into disparities in maternal and infant health. She is committed to promoting health and wellness by tackling modifiable risk factors, such as lifestyle changes and other non-pharmacological approaches.

Dr. Humphrey enjoys spending time with her husband and children. She also enjoys maintaining an active lifestyle, which includes mobility training, and powerlifting. Lastly, but foremost in her life, enjoys volunteering in her Christian Bible-based field ministry (Matthew 28:19-20).

“As a scientist and Board Certified Patient Advocate, my goal is to ensure that every voice is heard and valued, and to create a compassionate and empowering environment for informed decision-making, healing and wellness.” –Dr. Humphrey

Click here to learn more about Insightful Doc Consulting, LLC.

---

Publications

Co-Author – Publisher: Journal of the American Medical Association, September 28, 2022; Title: Effect of Dimethyl Fumarate vs Interferon β-1a in Patients with Pediatric-Onset Multiple Sclerosis (The CONNECT Randomized Clinical Trial)

The Connect Randomized Clinical Trial

Co-Author – Publisher: International Journal of MS Care, May 2022; Title: Diroximel Fumarate in Young Adults with Relapsing-Remitting Multiple Sclerosis: Interim Safety and Efficacy Results from the Phase 3 EVOLVE-MS-1 Study

International Journal of MS Care

Co-Author – Publisher: Fundamentals of International Regulatory Affairs, Fourth Edition/Regulatory Affairs Professional Society, September 2018; Chapter Title: Pharmaceutical Postmarketing Compliance

Fundamentals of International Regulatory Affairs, Fourth Edition

---

Professional Affiliations & Memberships

The National Association for Doctors of Public Health

National Association of Healthcare Advocacy

Alliance of Professional Health Advocates

Regulatory Affairs Professional Society

Breastfeeding USA

North Carolina Breastfeeding Coalition

Women in Bio

Professional Certifications

Board Certified Patient Advocate

Continuing Education

2025, Webinar, National Association of Healthcare Advocacy, The Age-friendly Advantage: Empowering Patients Using the 4Ms Framework

2025, Webinar, National Academy of Medicine, What Should Kids Eat? Ultra-Processed Foods and Children’s Health